Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.28 USD | +1.86% | -0.30% | +62.38% |
May. 10 | Leerink Partners Starts Aquestive Therapeutics With Outperform Rating, $8 Price Target | MT |
May. 08 | Transcript : Aquestive Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+62.38% | 299M | |
+32.36% | 694B | |
+29.59% | 593B | |
-1.60% | 371B | |
+20.07% | 331B | |
+6.04% | 290B | |
+14.47% | 239B | |
-3.56% | 209B | |
+10.06% | 209B | |
+9.27% | 169B |
- Stock Market
- Equities
- AQST Stock
- News Aquestive Therapeutics, Inc.
- Aquestive Therapeutics Proposes Public Stock Offering -- Shares Drop